Efficacy, safety and cost-effectiveness of insulin sensitizers as add-on therapy in metabolic syndrome in patients with secondary sulfonylurea failure: A comparative study.

Source:http://linkedlifedata.com/resource/pubmed/id/21350615

Download in:

View as

General Info

PMID
21350615